Optimizing the management of patients with chronic migraine and neck pain: a prospective randomized trial with long-term follow-up

Most patients with chronic migraine (CM) have musculoskeletal neck pain, which maintains the chronic course of migraine and complicates treatment. Cognitive behavioral therapy (CBT) is promising in the complex treatment of patients with CM and cervicalgia. However, few randomized trials have been conducted to evaluate the effectiveness of CBT in CM.
The aim of the study was to evaluate the effectiveness of an multidisciplinary program including CBT in the treatment of patients with CM and neck pain.
Material and methods. The study included 120 patients with CM and neck pain (41 men and 79 women), average age 35.7 ± 9.2 years. All patients underwent a clinical interview, neurological examination and testing using clinical and psychological methods. Patients were randomized into two groups: group 1 received standard treatment and CBT, group 2 — only standard treatment. All patients were assessed for clinical and psychological indicators before treatment and at 3, 6, 12 and 24 months follow-up.
Results. At 3 months follow-up, statistically significant (p < 0.05) improvement was observed in group 1: decrease in headache frequency, frequency and doses of taking painkillers (PK), neck pain intensity by the Visual Analogue Scale (VAS), the Total pericranial pain score, in the Migraine Disability Assessment (MIDAS), in the Neck Disability Index (NDI), in the Pain catastrophizing scale, the State-Trait Anxiety Inventory, the Center for Epidemiologic Studies Depression Scale. At 6, 12 and 24 months follow-up, the achieved improvements were maintained. In group 2, at 3 months follow-up, statistically significant improvement was observed in only six indicators — headache frequency, frequency and doses of taking PK, neck pain intensity by VAS, MIDAS and NDI. However, at 6, 12 and 24 months of follow-up the achieved improvements were not maintained in group 2. At 3 months of follow-upin group 1 was clinical efficacy (CE) for CM (decrease in headache frequency by 50% or more) and CE for neck pain (decrease in pain intensity by VAS and the NDI by 30% or more) achieved by 75% of patients, in group 2 — 45% (p < 0.001). At 24 months follow-up in group 1 CE for CM and neck pain was achieved by 80% of patients, in group 2 — 30%.
Conclusion. An multidisciplinary program including CBT is significantly more effective than standard treatment for chronic migraine and neck in the short and long term.

1. The International Classification of Headache Disorders, 3 rd edition (ICHD-3). Cephalalgia. 2018;38(1):1–211. https://doi.org/10.1177/0333102417738202

2. Ayzenberg I, Katsarava Z, Sborowski A, Chernysh M, Osipova V, Tabeeva G, Yakhno N, Steiner TJ; Lifting the Burden. The prevalence of primary headache disorders in Russia: a countrywide survey. Cephalalgia. 2012;32(5):373–381. https://doi.org/10.1177/0333102412438977

3. Steiner TJ, Birbeck GL, Jensen RH, Katsarava Z, Stovner LJ, Martelletti P. Headache disorders are third cause of disability worldwide. J Headache Pain. 2015;16:58. https://doi.org/10.1186/s10194-015-0544-2

4. Burch RC, Buse DC, Lipton RB. Migraine: Epidemiology, Burden, and Comorbidity. Neurol Clin. 2019;37(4):631–649.https://doi.org/10.1016/j.ncl.2019.06.001

5. Buse DC, Greisman JD, Baigi K, Lipton RB. Migraine Progression: A Systematic Review. Headache. 2019;59(3):306–338. https://doi.org/10.1111/head.13459

6. Filatova E.G., Osipova V.V., Tabeeva G.R., Parfenov V.A., Ekusheva E.V., Azimova Yu.E., Latysheva N.V., Naprienko M.V., Skorobogatykh K.V., Sergeev A.V., Golovacheva V.A., Lebedeva E.R., Artyomenko A.R., Kurushina O.V., Koreshkina M.I., Amelin A.V., Akhmadeeva L.R., Rachin A.R., Isagulyan E.D., Danilov A.B., Gekht A.B. Diagnosis and treatment of migraine: Russian experts’ recommendations. Neurology, Neuropsychiatry, Psychosomatics. 2020;12(4):4–14. (In Russ.) https://doi.org/10.14412/2074-2711-2020-4-4-14

7. Мигрень. Клинические рекомендации МЗ РФ. 2021. ID: 295. Доступно по ссылке: https://cr.minzdrav.gov.ru/recomend/295_2

8. Amelin A.V., Sokolov A.Yu., Vaganova Yu.S. Five-year experience of using a new class of drugs for targeted preventive therapy of migraine. Russian neurological journal. 2021;26(3):4–14. (In Russ.) https://doi.org/10.30629/2658-7947-2021-26-3-4-14

9. Giri S, Tronvik E, Linde M, Pedersen SA, Hagen K. Randomized controlled studies evaluating Topiramate, Botulinum toxin type A, and mABs targeting CGRP in patients with chronic migraine and medication overuse headache: A systematic review and meta-analysis. Cephalalgia. 2023;43(4):3331024231156922. https://doi.org/10.1177/03331024231156922

10. Ashina S, Bendtsen L, Lyngberg AC, Lipton RB, Hajiyeva N, Jensen R. Prevalence of neck pain in migraine and tension-type headache: a population study. Cephalalgia. 2015;35(3):211–219. https://doi.org/10.1177/0333102414535110

11. Parfenov VA, Yakhno NN, Kukushkin ML, Davydov OS, Churyukanov MV, Golovacheva VA, Evzikov GY, Isaikin AI, Bakhtadze MA, Medvedeva LA, Kalinsky PP, Shirokov VA. Non-specific neck pain (cervicalgia). Guidelines of the Russian Society for the Study of Pain (RSSP). Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2023;15(5):4–12. (In Russ.) https://doi.org/10.14412/2074-27112023-5-4-12

12. May A, Schulte LH. Chronic migraine: risk factors, mechanisms and treatment. Nat Rev Neurol. 2016;12(8):455–464. https://doi.org/10.1038/nrneurol.2016.93

13. Lampl C, Rudolph M, Deligianni CI, Mitsikostas DD. Neck pain in episodic migraine: premonitory symptom or part of the attack?. J Headache Pain. 2015;16:566. https://doi.org/10.1186/s10194-015-0566-9

14. Pradhan S, Choudhury SS. Clinical characterization of neck pain in migraine. Neurol India. 2018;66(2):377–384. https://doi.org/10.4103/0028-3886.227302

15. Castien R, Duineveld M, Maaskant J, De Hertogh W, Scholten-Peeters G. Pericranial Total Tenderness Score in Patients with Tension-type Headache and Migraine. A Systematic Review and Meta-analysis. Pain Physician. 2021;24(8):E1177-E1189. Available at: https://pubmed.ncbi.nlm.nih.gov/34793636/

16. Modarresi S, Lukacs MJ, Ghodrati M, Salim S, MacDermid JC, Walton DM; CATWAD Consortium Group. A Systematic Review and Synthesis of Psychometric Properties of the Numeric Pain Rating Scale and the Visual Analog Scale for Use in People With Neck Pain. Clin J Pain. 2021 Oct 26;38(2):132–148. https://doi.org/10.1097/AJP.0000000000000999

17. Julian LJ. Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A). Arthritis Care Res (Hoboken). 2011;63 Suppl 11(0 11):S467-S472. https://doi.org/10.1002/acr.20561

18. Henry SK, Grant MM, Cropsey KL. Determining the optimal clinical cutoff on the CES-D for depression in a community corrections sample. J Affect Disord. 2018 Jul;234:270–275. https://doi.org/10.1016/j.jad.2018.02.071

19. Ikemoto T, Hayashi K, Shiro Y, et al. A systematic review of cross-cultural validation of the pain catastrophizing scale. Eur J Pain. 2020;24(7):1228–1241. https://doi.org/10.1002/ejp.1587

20. Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology. 2001;56(6 Suppl 1):S20-S28. https://doi.org/10.1212/wnl.56.suppl_1.s20

21. Vernon H. The Neck Disability Index: state-of-the-art, 1991-2008. J Manipulative Physiol Ther. 2008;31(7):491–502. https://doi.org/10.1016/j.jmpt.2008.08.006

22. Tabeeva G.R., Osipova V.V., Filatova E.G., Azimova Yu.E., Amelin A.V., Artyomenko A.R., Vorobyeva Yu.D., Ekusheva E.V., Koreshkina M.I., Lebedeva E.R., Latysheva N.V., Naprienko M.V., Sergeev A.V., Skorobogatykh K.V., Golovacheva V.A., Rachin A.P., Parfenov V.A. Evaluationandtreatmentofmedication-overuseheadache: Russianexperts’ guidelines. Neurology, Neuropsychiatry, Psychosomatics. 2022;14(1):4–13. (In Russ.) https://doi.org/10.14412/2074-2711-2022-1-4-13

23. Golovacheva VA, Golovacheva AA. Treatment of chronic migraine and neck pain with cognitive-behavioral therapy. Case report. Consilium Medicum. 2021;23(11):852–857. DOI: 10.26442/20751753.2021.11.201137

24. Golovacheva V.A., Golovacheva A.A., Parfenov V.A., Tabeeva G.R., Romanov D.V., Osipova V.V., Katsarava Z. Cognitive behavioral therapy in the treatment of chronic migraine: a clinical case report. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(1):74–80. (In Russ.) https://doi.org/10.14412/2074-2711-2021-1-74-80

25. Golovacheva VA, Golovacheva AA, Parfenov VA. Chronic migraine treatment: multidisciplinary approach. Case report. Terapevticheskii Arkhiv (Ter. Arkh.). 2021;93(12):1528–1532. DOI: 10.26442/00403660.2021.12.201247

26. GolovachevaVA, GolovachevaAA, FateevaTG, ParfenovVA. Cognitive behavioral therapy in the treatment of patients with chronic migraine and concomitant chronic insomnia: a prospective, randomized trial. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(5 vyp 2):110–117. (In Russ.). https://doi.org/10.17116/jnevro2024124052110

27. Golovacheva V.A. Treatment of chronic migraine and insomnia with cognitive behavioral therapy. Meditsinskiy sovet = Medical Council. 2023;(3):68–76. (In Russ.) https://doi.org/10.21518/ms2023-080

28. Golovacheva V.A. Interdisciplinary treatment including cognitive behavioral therapy and mindfulness for chronic migraine and drug-induced headache. Meditsinskiy sovet = Medical Council. 2023;(10):80–88. (In Russ.) https://doi.org/10.21518/ms2023-216

29. Bae JY, Sung HK, Kwon NY, Go HY, Kim TJ, Shin SM, Lee S. Cognitive Behavioral Therapy for Migraine Headache: A Systematic Review and Meta-Analysis. Medicina (Kaunas). 2021 Dec 28;58(1):44. https://doi.org/10.3390/medicina58010044

30. Harris P, Loveman E, Clegg A, Easton S, Berry N. Systematic review of cognitive behavioural therapy for the management of headaches and migraines in adults. Br. J. Pain. 2015;9(4):213–224.

31. Probyn K, Bowers H, Mistry D, Caldwell F, Underwood M, Patel S, Sandhu HK, Matharu M, Pincus T; CHESS team. Non-pharmacological self-management for people living with migraine or tension-type headache: a systematic review including analysis of intervention components. BMJ Open. 2017;7(8):e016670. https://doi.org/10.1136/bmjopen-2017-016670

32. Lee HJ, Lee JH, Cho EY, Kim SM, Yoon S. Efficacy of psychological treatment for headache disorder: a systematic review and meta-analysis. J. Headache Pain. 2019;20(1):17. https://doi.org/10.1186/s10194-019-0965-4

33. Sharpe L, Dudeney J, Williams ACDC, Nicholas M, McPhee I, Baillie A, Welgampola M, McGuire B. Psychological therapies for the prevention of migraine in adults. Cochrane Database of Systematic Reviews 2019, Issue 7. Art. No.: CD012295. https://doi.org/10.1002/14651858.CD012295.pub2

34. Beck AT. A 60-Year Evolution of Cognitive Theory and Therapy. Perspect Psychol Sci. 2019;14(1):16–20. https://doi.org/10.1177/1745691618804187

35. Golovacheva V.A., Golovacheva A.A., Fateeva T.G., Volodarskaya E.A. Illness perception in patients with chronic migraine: cognitive, emotional and behavioral aspects. Neurology, Neuropsychiatry, Psychosomatics. 2023;15(1):28–35. (In Russ.) https://doi.org/10.14412/2074-2711-2023-1-28-35